8,700 Studies Reviewed. 87.0% Found Biological Effects. The Evidence is Clear.

Hernández-Morales M, Shang T, Chen J, Han V, Liu C

Bioeffects Seen

Authors not listed · 2020

Share:

Coronavirus research reveals mitochondrial vulnerabilities that EMF studies suggest may be amplified by electromagnetic field exposure.

Plain English Summary

Summary written for general audiences

This study analyzed how three coronaviruses (SARS-CoV-1, SARS-CoV-2, and MERS-CoV) interact with human proteins inside cells. Researchers identified specific cellular proteins that these viruses hijack to replicate, including a mitochondrial protein called Tom70. The findings could help identify new drug targets for treating COVID-19 and related coronavirus infections.

Why This Matters

While this coronavirus research doesn't directly address EMF health effects, it highlights something crucial that EMF researchers have been documenting for years: the vulnerability of mitochondria to environmental stressors. The study identifies Tom70, a mitochondrial chaperone protein, as a key target that coronaviruses exploit for replication. What's significant is that independent research has shown EMF exposure can disrupt mitochondrial function through similar pathways. This creates a concerning scenario where EMF-compromised cellular energy systems might be more susceptible to viral hijacking. The reality is that our cells face multiple environmental challenges simultaneously, and understanding how EMF exposure affects the same cellular machinery that viruses target becomes increasingly important for comprehensive health protection.

Exposure Information

Specific exposure levels were not quantified in this study.

Cite This Study
Unknown (2020). Hernández-Morales M, Shang T, Chen J, Han V, Liu C.
Show BibTeX
@article{hernndez_morales_m_shang_t_chen_j_han_v_liu_c_ce2412,
  author = {Unknown},
  title = {Hernández-Morales M, Shang T, Chen J, Han V, Liu C},
  year = {2020},
  doi = {10.1126/SCIENCE.ABE9403},
  
}

Quick Questions About This Study

Coronaviruses like SARS-CoV-2 interact with specific human proteins to commandeer cellular machinery for replication. This study identified key protein interactions, including with Tom70, a mitochondrial chaperone that helps viruses establish infection and reproduce within host cells.
Tom70 is a mitochondrial chaperone protein that helps other proteins function properly in cellular powerhouses. Both SARS-CoV-1 and SARS-CoV-2 specifically target Tom70 to hijack mitochondrial processes, making it a potential therapeutic target for coronavirus treatments.
Researchers compared three coronaviruses: SARS-CoV-1, SARS-CoV-2 (COVID-19), and MERS-CoV. They analyzed how each virus interacts with human proteins to understand common infection mechanisms and identify shared vulnerabilities for potential drug development.
Scientists used functional genetic screening to identify human proteins that affect coronavirus replication. They combined this with COVID-19 patient genetic data and medical records to validate which host factors are clinically relevant for infection outcomes.
By identifying specific human proteins that coronaviruses depend on, like Tom70, researchers can develop drugs that block these interactions. This approach targets the host factors viruses need rather than just the virus itself, potentially creating more effective treatments.